Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)
China
· Delayed Price · Currency is CNY 34.40
-0.30 (-0.86%)
Nov 13, 2024, 3:00 PM CST
Tianjin Pharmaceutical Da Ren Tang Group Corporation Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 8,024 | 8,206 | 8,231 | 6,892 | 6,590 | 6,975 | Upgrade
|
| Other Revenue | 16.23 | 16.23 | 17.87 | 15.33 | 13.64 | 19.25 | Upgrade
|
| Revenue | 8,040 | 8,222 | 8,249 | 6,908 | 6,604 | 6,994 | Upgrade
|
| Revenue Growth (YoY) | -5.18% | -0.33% | 19.42% | 4.60% | -5.58% | 9.99% | Upgrade
|
| Cost of Revenue | 4,301 | 4,632 | 4,992 | 4,161 | 4,024 | 4,073 | Upgrade
|
| Gross Profit | 3,739 | 3,590 | 3,258 | 2,747 | 2,580 | 2,921 | Upgrade
|
| Selling, General & Admin | 2,619 | 2,508 | 2,347 | 1,930 | 1,815 | 2,194 | Upgrade
|
| Research & Development | 196.93 | 184.63 | 153.15 | 161.05 | 149.2 | 133.36 | Upgrade
|
| Other Operating Expenses | 94.3 | 79.05 | 76.69 | 64.12 | 58.29 | 65.46 | Upgrade
|
| Operating Expenses | 2,942 | 2,791 | 2,586 | 2,160 | 2,029 | 2,392 | Upgrade
|
| Operating Income | 796.76 | 799.27 | 671.32 | 587.04 | 551.04 | 528.19 | Upgrade
|
| Interest Expense | -37.65 | -35.85 | -10.27 | -2.94 | -0.01 | -4.89 | Upgrade
|
| Interest & Investment Income | 301.51 | 362.75 | 330.35 | 263.97 | 188.48 | 200.93 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.13 | -1.13 | -2.44 | 0.69 | 1.73 | -0.47 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.94 | -1.73 | 3.63 | -5.3 | -6.27 | -3.23 | Upgrade
|
| EBT Excluding Unusual Items | 1,062 | 1,123 | 992.59 | 843.46 | 734.98 | 720.52 | Upgrade
|
| Impairment of Goodwill | -18.78 | -18.78 | -19.57 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -3.31 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.52 | -0.48 | 0.67 | 10.39 | 6.62 | 29.16 | Upgrade
|
| Asset Writedown | -20.24 | -24.95 | -0.18 | - | - | - | Upgrade
|
| Other Unusual Items | 34.6 | 16.27 | 6.67 | 18.96 | 26.46 | -3.23 | Upgrade
|
| Pretax Income | 1,057 | 1,095 | 980.19 | 872.81 | 768.06 | 743.15 | Upgrade
|
| Income Tax Expense | 137.67 | 126.66 | 106.93 | 85.93 | 88.4 | 107.79 | Upgrade
|
| Earnings From Continuing Operations | 919.82 | 968.71 | 873.26 | 786.88 | 679.66 | 635.36 | Upgrade
|
| Minority Interest in Earnings | 12.56 | 18 | -11.46 | -17.73 | -17.96 | -9.79 | Upgrade
|
| Net Income | 932.37 | 986.71 | 861.79 | 769.14 | 661.7 | 625.57 | Upgrade
|
| Net Income to Common | 932.37 | 986.71 | 861.79 | 769.14 | 661.7 | 625.57 | Upgrade
|
| Net Income Growth | -5.92% | 14.49% | 12.05% | 16.24% | 5.78% | 11.37% | Upgrade
|
| Shares Outstanding (Basic) | 771 | 771 | 769 | 769 | 769 | 772 | Upgrade
|
| Shares Outstanding (Diluted) | 771 | 771 | 776 | 769 | 769 | 772 | Upgrade
|
| Shares Change (YoY) | -0.51% | -0.71% | 0.94% | -0.04% | -0.37% | 0.37% | Upgrade
|
| EPS (Basic) | 1.21 | 1.28 | 1.12 | 1.00 | 0.86 | 0.81 | Upgrade
|
| EPS (Diluted) | 1.21 | 1.28 | 1.11 | 1.00 | 0.86 | 0.81 | Upgrade
|
| EPS Growth | -5.44% | 15.32% | 11.00% | 16.28% | 6.17% | 10.96% | Upgrade
|
| Free Cash Flow | 1,038 | 547.56 | 569.34 | 695.45 | 482.26 | 289.87 | Upgrade
|
| Free Cash Flow Per Share | 1.35 | 0.71 | 0.73 | 0.90 | 0.63 | 0.38 | Upgrade
|
| Dividend Per Share | 1.280 | 1.280 | 1.120 | 0.500 | 0.300 | 0.300 | Upgrade
|
| Dividend Growth | 14.29% | 14.29% | 124.00% | 66.67% | 0% | 36.36% | Upgrade
|
| Gross Margin | 46.50% | 43.66% | 39.49% | 39.76% | 39.07% | 41.76% | Upgrade
|
| Operating Margin | 9.91% | 9.72% | 8.14% | 8.50% | 8.34% | 7.55% | Upgrade
|
| Profit Margin | 11.60% | 12.00% | 10.45% | 11.13% | 10.02% | 8.94% | Upgrade
|
| Free Cash Flow Margin | 12.91% | 6.66% | 6.90% | 10.07% | 7.30% | 4.14% | Upgrade
|
| EBITDA | 923.83 | 923.54 | 786.15 | 701.29 | 660.9 | 625.34 | Upgrade
|
| EBITDA Margin | 11.49% | 11.23% | 9.53% | 10.15% | 10.01% | 8.94% | Upgrade
|
| D&A For EBITDA | 127.07 | 124.27 | 114.83 | 114.25 | 109.85 | 97.16 | Upgrade
|
| EBIT | 796.76 | 799.27 | 671.32 | 587.04 | 551.04 | 528.19 | Upgrade
|
| EBIT Margin | 9.91% | 9.72% | 8.14% | 8.50% | 8.34% | 7.55% | Upgrade
|
| Effective Tax Rate | 13.02% | 11.56% | 10.91% | 9.85% | 11.51% | 14.50% | Upgrade
|
| Revenue as Reported | 8,040 | 8,222 | 8,249 | 6,908 | 6,604 | 6,994 | Upgrade
|
| Advertising Expenses | - | - | - | 321.16 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.